Market Consultation for the Supply of Sole Source Medicines to the HSE

Description

Market engagement: The HSE wishes to establish a list of authorised medicinal products which are marketed and which are only commercially available from a single source in the Republic of Ireland, as of the date for return of responses to this consultation (i.e. 04/09/2023). ** On 13/12/2019, the HSE published a Prior Information Notice (PIN) (OJEU ref: 2019/S 243-596458) seeking to establish a list of authorised medicinal products which are marketed and are only commercially available from a single source in the Republic of Ireland, as of the date for return of responses to the PIN (i.e. 24/01/2020). The HSE published the outcome of this process on 7th September 2020 (OJEU ref:2020/S 177-424875). As part of the ongoing additions and amendments to this list, the HSE now wishes to communicate the updated outcome of this exercise to the marketplace, please refer to the document attached HSE 22316 Appendix 1 - Sole Source List. Market engagement: The HSE wishes to establish a list of authorised medicinal products which are marketed and which are only commercially available from a single source in the Republic of Ireland, as of the date for return of responses to this consultation (i.e. 04/09/2023). ** On 13/12/2019, the HSE published a Prior Information Notice (PIN) (OJEU ref: 2019/S 243-596458) seeking to establish a list of authorised medicinal products which are marketed and are only commercially available from a single source in the Republic of Ireland, as of the date for return of responses to the PIN (i.e. 24/01/2020). The HSE published the outcome of this process on 7th September 2020 (OJEU ref:2020/S 177-424875). As part of the ongoing additions and amendments to this list, the HSE now wishes to communicate the updated outcome of this exercise to the marketplace, please refer to the document attached HSE 22316 Appendix 1 - Sole Source List.